Organs & Tissue Transplant

Allogeneic Bone Marrow Transplant—also known as an allogeneic stem cell transplant—is a life-saving procedure where a patient receives healthy stem cells from a donor to replace their own diseased or damaged marrow. Primarily used for aggressive blood cancers and non-malignant conditions like Thalassemia, this procedure introduces a new immune system into the patient’s body. Modern clinical protocols and advanced matching technologies have made this a highly successful intervention for patients with complex hematological disorders.

When You Should Consider Allogeneic BMT

• Diagnosis of Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL) with high-risk features.

• Severe Aplastic Anemia where the bone marrow has stopped producing enough blood cells.

• Presence of inherited blood disorders such as Thalassemia Major or Sickle Cell Anemia.

• Myelodysplastic Syndromes (MDS) that show signs of progressing toward leukemia.

• Certain types of aggressive Lymphoma that have relapsed after an autologous transplant.

• Chronic Myeloid Leukemia (CML) that has become resistant to standard targeted therapies.

Conditions That Require Specialized Care

• High-risk Leukemia requiring a powerful "Graft-versus-Tumor" effect to prevent relapse.

• Pediatric Thalassemia requiring permanent correction of hemoglobin production.

• Rare primary immunodeficiency disorders where the patient lacks a functional immune system.

• Bone marrow failure syndromes requiring a complete replacement of the hematopoietic system.

• Metabolic disorders that can be corrected by introducing healthy donor enzymes via stem cells.

How Allogeneic Bone Marrow Transplant Is Performed

• A donor search is conducted to find a close Human Leukocyte Antigen (HLA) match.

• The patient undergoes "Conditioning" with high-dose chemotherapy or radiation to suppress their immune system.

• Healthy stem cells are collected from the donor's bone marrow or peripheral blood.

• On the day of the transplant, donor cells are infused into the patient’s bloodstream through a central venous catheter.

• The patient remains in a sterile, HEPA-filtered isolation room to prevent infection during the "neutral" phase.

• Infused donor cells migrate to the marrow space and begin producing new, healthy blood cells (Engraftment).

Modern Innovations in Allogeneic BMT

• Haploidentical (Half-Match) ProtocolsAdvanced techniques that allow parents or children to serve as donors with success rates comparable to full matches.

• T-Cell Depletion & ModulationPrecision laboratory methods that remove specific donor cells responsible for GVHD while keeping those that fight cancer.

• Next-Generation Sequencing (NGS) HLA MatchingUltra-high-resolution DNA matching that identifies the most compatible donor at the molecular level.

• Reduced Intensity Conditioning (RIC)"Mini-transplants" that use lower doses of chemo, making the procedure safer for older or more fragile patients.

• Microbiome-Preserving ProtocolsSpecialized nutritional and antibiotic strategies that protect the gut health to reduce the risk of post-transplant complications.

• Post-Transplant Cyclophosphamide (PTCy)A breakthrough medication protocol that significantly lowers the incidence of Graft-versus-Host Disease in mismatched cases.

Donor Types and Selection

• Matched Related Donor (MRD)The gold standard, typically a sibling who shares identical genetic markers (10/10 HLA match).

• Matched Unrelated Donor (MUD)A compatible volunteer identified through international bone marrow registries.

• Haploidentical DonorA biological parent or child who is a 50% genetic match, now widely used due to improved safety protocols.

• Umbilical Cord BloodRich in stem cells, cord blood can be used for patients who cannot find a suitable adult donor.

Pre-Procedure Preparation

• Rigorous HLA testing of the patient and potential family donors to find the best possible match.

• Evaluation by a multidisciplinary team including hematologists, infectious disease specialists, and nutritionists.

• Placement of a multi-lumen central venous catheter for chemotherapy, cell infusion, and blood sampling.

• Extensive counseling on the long-term recovery process and the management of a new immune system.

• Dental and sinus clearances to ensure there are no dormant infections prior to the conditioning phase.

Pre-Procedure Tests

• High-resolution HLA typing (Class I and II) to confirm donor compatibility.

• Bone marrow aspiration and biopsy to establish the baseline disease status.

• Organ function tests including Echocardiogram, PFTs (Lungs), and Kidney function panels.

• Comprehensive viral screening for CMV, EBV, HIV, and Hepatitis for both donor and recipient.

• Cross-matching and donor-specific antibody (DSA) testing to prevent graft rejection.

Why This Treatment Is Highly Effective

• Provides a "Graft-versus-Tumor" (GVT) effect, where the new immune system actively hunts and kills cancer cells.

• Offers the only potential cure for many aggressive forms of leukemia and bone marrow failure.

• Successfully cures pediatric Thalassemia in a high majority of cases, eliminating the need for lifelong transfusions.

• Modern supportive care has significantly reduced the historical risks of infection and organ damage.

• Technological advances allow for successful transplants even without a perfectly matched sibling.

Recovery and Monitoring

• The "Engraftment" period (2–3 weeks) requires intensive monitoring for fever and blood count recovery.

• Patients remain on immunosuppressant medications for several months to prevent Graft-versus-Host Disease (GVHD).

• Full immune system reconstitution typically takes 6 to 12 months, during which special precautions are needed.

• Frequent blood tests and chimeric studies are done to ensure the donor cells have successfully "taken over."

• Gradual re-introduction to social environments occurs as white blood cell levels stabilize.

Life After Allogeneic BMT

• Long-term remission and potential cure from previously fatal blood disorders.

• A personalized re-vaccination schedule to rebuild immunity from the "donor's" perspective.

• Regular monitoring for chronic GVHD, which can affect the skin, eyes, or liver.

• Return to a full, active life, including school or work, once the immune system is mature.

• Ongoing partnership with the transplant team to ensure long-term wellness and disease-free survival.

Autologous Bone Marrow Transplant—also known as an autologous stem cell transplant—is a sophisticated procedure used to treat various blood cancers and severe autoimmune diseases. This treatment involves using the patient's own healthy stem cells to "rescue" the bone marrow after it has been cleared of disease by high-dose chemotherapy or radiation. By utilizing the patient's own biological material, this procedure eliminates the risk of donor-related complications and provides a powerful pathway to remission.

When You Should Consider ABMT

• Diagnosis of Multiple Myeloma where transplant is recommended as a primary frontline therapy.

• Relapsed or refractory Hodgkin’s or Non-Hodgkin’s Lymphoma that has not responded to standard chemotherapy.

• Certain germ cell tumors that have returned after initial treatment.

• Severe, treatment-resistant autoimmune diseases such as Multiple Sclerosis (MS) or Systemic Sclerosis.

• Presence of high-risk neuroblastoma in pediatric cases where aggressive therapy is required.

• Recommendation for high-dose "conditioning" therapy that would otherwise permanently damage bone marrow function.

Conditions That Require Specialized Care

• Multiple Myeloma requiring long-term marrow stabilization and disease control.

• Relapsed Lymphoma where the goal is to achieve deep, durable remission.

• Severe Crohn's Disease or other autoimmune conditions that have failed all standard biologic therapies.

• Amyloidosis, a rare protein disorder that can affect organ function.

• Specific types of leukemia that are in remission but carry a high risk of recurrence.

How Autologous Bone Marrow Transplant Is Performed

• Stem cells are mobilized from the bone marrow into the bloodstream using growth factor injections.

• Healthy stem cells are harvested via Apheresis, where blood is filtered through a specialized machine.

• The collected stem cells are cryopreserved (frozen) and safely stored in a laboratory.

• The patient undergoes high-dose "Conditioning" (chemotherapy or radiation) to eliminate remaining cancer cells.

• The frozen stem cells are thawed and reinfused into the bloodstream, much like a standard blood transfusion.

• The infused cells migrate to the bone marrow (Engraftment) and begin producing new, healthy blood cells.

Innovations in Autologous Transplant

• Advanced Apheresis TechnologyHigh-efficiency cell separators that maximize the yield of healthy stem cells while reducing the time spent on the machine.

• Next-Generation Mobilization AgentsThe use of precision medications that more effectively push stem cells into the bloodstream, even for "poor mobilizers."

• Real-Time CD34+ TrackingSophisticated laboratory monitoring that identifies the exact hour of peak stem cell concentration for optimal harvesting.

• Targeted Conditioning RegimensRefined chemotherapy protocols designed to maximize cancer cell death while minimizing damage to healthy organs.

• Rapid Engraftment MonitoringMolecular tools that detect the earliest signs of new blood cell production, allowing for faster discharge from the hospital.

• Automated Thawing SystemsDigitally controlled warming devices that protect the delicate cell membranes during the transition from ice to infusion.

Pre-Procedure Preparation

• Extensive physical evaluation to ensure the heart, lungs, and kidneys can tolerate high-dose therapy.

• Dental clearance to eliminate any hidden sources of infection before the immune system is suppressed.

• Placement of a central venous catheter (PICC or Hickman line) for easy blood access and infusion.

• Coordination of a 3-to-6-week hospital stay in a specialized, HEPA-filtered isolation room.

• Nutritional optimization and psychological counseling to prepare for the intensive recovery period.

Pre-Procedure Tests

• Bone Marrow Aspiration and Biopsy to confirm the status of the underlying disease.

• High-resolution PET/CT scans to map the location and extent of any remaining cancer cells.

• Echocardiogram or MUGA scan to assess cardiac output and heart health.

• Pulmonary Function Tests (PFTs) to ensure the lungs can handle systemic treatment.

• Comprehensive blood panels, including viral markers and organ function profiles.

Why This Treatment Is Highly Effective

• Eliminates the risk of Graft-versus-Host Disease (GVHD), as the body recognizes the cells as its own.

• Allows for the use of "curative" doses of chemotherapy that would be impossible without a stem cell rescue.

• Features high success rates, with durable remission seen in a significant majority of Multiple Myeloma patients.

• Significantly improves survival outcomes and quality of life in relapsed lymphoma cases.

• Offers a potential "reset" for the immune system in patients with aggressive autoimmune disorders.

Recovery and Monitoring

• The "Engraftment" phase typically takes 10 to 14 days, during which the patient is closely monitored for infections.

• Daily blood counts are performed to track the rise of white blood cells, red blood cells, and platelets.

• Supportive care, including blood transfusions and IV antibiotics, is provided until the new marrow is functional.

• Patients remain in a protective environment until their absolute neutrophil count reaches a safe level.

• Long-term follow-up involves monitoring for "late effects" and ensuring the disease remains in remission.

Life After Autologous Transplant

• Gradual return to daily activities as the immune system slowly recovers over several months.

• Long-term disease management, which may include maintenance therapy to prevent recurrence.

• Re-vaccination protocols, as the transplant often "wipes out" previous immunity to childhood diseases.

• Regular oncology or hematology check-ups with advanced imaging and blood markers.

• Empowerment through the successful completion of one of the most intensive and effective medical treatments available

A bone marrow transplant (BMT), also called a Hematopoietic Stem Cell Transplant, is a procedure that replaces diseased or damaged bone marrow with healthy stem cells. These stem cells are the "factories" that produce your red blood cells, white blood cells, and platelets.

When You Should Consider Bone Marrow Transplant

• To replace non-functioning marrow in conditions such as Aplastic Anemia.

• To "rescue" the marrow after high-dose chemotherapy for Leukemia, Lymphoma, or Multiple Myeloma.

• To replace "broken" or genetically abnormal cells in disorders like Sickle Cell Disease or Thalassemia.

• When other primary treatments have failed and a transplant offers the only curative option.

• Following the identification of a matched donor or the successful collection of own healthy stem cells.

Methods of Bone Marrow Transplant

• Autologous Transplant: A procedure using the patient's own stem cells, which are collected and frozen before intensive treatment.

• Allogeneic Transplant: A transplant using stem cells from a matched relative or an unrelated volunteer donor.

• Matched Sibling Donor: Using a brother or sister who has the same human leukocyte antigen (HLA) type.

• Haploidentical Transplant: A type of allogeneic transplant using a donor who is a "half-match," such as a parent or child.

• Umbilical Cord Blood Transplant: Using stem cells harvested from the umbilical cord and placenta after a baby is born.

How Bone Marrow Transplant Is Performed

• Conditioning: Administration of high-dose chemotherapy or radiation over 5–7 days to clear out old marrow.

• Stem Cell Infusion: Healthy cells are infused through a central venous catheter (PICC or Hickman line), similar to a blood transfusion.

• Engraftment: A 2–4 week period where the new cells travel to the bones and begin producing new blood cells.

• Immune Reset: The process of the new immune system gradually maturing and learning to protect the body.

• Continuous Monitoring: Intensive observation in the hospital to manage the high risk of infection during the recovery phase.

Pre-Procedure Preparation

• Extensive work-up testing of the heart, lungs, and kidneys to ensure the body can handle the procedure.

• Placement of a central venous catheter for the infusion of cells and administration of medications.

• Coordination of stem cell collection (apheresis) for autologous patients or donor matching for allogeneic patients.

• Understanding the "Point of No Return" during the conditioning phase where the old marrow is destroyed.

Tests Before Bone Marrow Transplant

• HLA Typing: A specialized blood test used to match patients with the most compatible donors.

• Bone Marrow Biopsy: To assess the current state of the marrow and the presence of any remaining cancer cells.

• Organ Function Screens: Detailed evaluations including ECGs, lung function tests, and kidney filtration checks.

• Infectious Disease Screening: Comprehensive testing for viruses or bacteria that could become dangerous during recovery.

Life After Bone Marrow Transplant

• Most patients remain hospitalized for 3–5 weeks following the infusion.

• Long-term recovery is a gradual process requiring close medical supervision for up to a year.

• Patients must follow strict infection-prevention protocols while their immune system is "reset" to zero.

• Ongoing management may include anti-rejection medications to prevent Graft-vs-Host Disease (GVHD).

Benefits of Bone Marrow Transplant

• Provides a curative pathway for many blood cancers that are resistant to standard chemotherapy.

• Restores the body's ability to produce healthy, functional red blood cells, white blood cells, and platelets.

• Corrects the underlying genetic "blueprints" in patients with hereditary blood disorders.

• Offers a chance for long-term remission and the restoration of a healthy immune system.

A haploidentical transplant is a type of allogeneic bone marrow transplant that uses a half-matched donor. While traditional transplants usually require a 100% HLA match, this procedure utilizes a donor who is a 50% match, significantly expanding the donor pool for patients who cannot find a perfect match in international registries.

When You Should Consider Haploidentical Transplant

• When a 100% HLA-matched sibling or unrelated donor is not available.

• For patients requiring an urgent transplant where a family member can be screened and ready in days.

• When the "mismatch" effect is desired to help new cells identify and eliminate remaining cancer (Graft-vs-Leukemia effect).

• For those who have a biological parent, child, or half-matched sibling available to donate.

Methods of Haploidentical Transplant

• Parental Donation: Utilizing a biological parent as the 50% HLA match.

• Child Donation: Utilizing a biological child as the 50% HLA match.

• Sibling Half-Match: Utilizing a biological sibling who shares half of the inherited HLA markers.

• Post-Transplant Cyclophosphamide (PTCy): A specialized protocol using high-dose chemotherapy after infusion to ensure safety.

How Haploidentical Transplant Is Performed

• Conditioning: Administration of chemotherapy or radiation to eliminate diseased marrow.

• Stem Cell Infusion: Infusing donor stem cells through a central line, similar to a blood transfusion.

• PTCy Administration: Delivering high-dose Cyclophosphamide on days 3 and 4 post-infusion to selectively kill cells that cause rejection.

• Engraftment waiting period: A 2 to 3-week phase where the new cells begin producing white blood cells, red cells, and platelets.

• Immunosuppression: Using specific medications to maintain balance in the new immune system.

Pre-Procedure Preparation

• Identifying and screening a biological family member who is a 50% HLA match.

• Educating the patient on the unique PTCy safety phase following the stem cell infusion.

• Baseline health assessments to ensure the patient can handle the intensive conditioning phase.

• Preparing for a longer hospital stay, typically between 3 to 5 weeks.

Tests Before Haploidentical Transplant

• HLA Typing: Identifying the 50% match markers inherited from parents.

• Donor Screening: Rapid testing and medical clearance of the identified family member.

• Viral Screening: Detailed testing for viruses like CMV, as there is a higher infection risk post-procedure.

• Marrow Assessment: Evaluating the status of the diseased marrow prior to the conditioning phase.

Life After Haploidentical Transplant

• Most patients remain in the hospital for 3 to 5 weeks following the procedure.

• Close outpatient monitoring is required for at least the first 100 days.

• A slightly longer recovery period for the immune system compared to a full-match transplant.

• Ongoing use of immunosuppressant medications to prevent Graft-versus-Host Disease (GVHD).

Benefits of Haploidentical Transplant

• Provides a nearly universal donor source since most people have a half-matched family member.

• Allows for a much faster donor identification and screening process compared to unrelated registries.

• Utilizes the Graft-vs-Leukemia effect, where the mismatch helps kill residual cancer cells.

• Modern PTCy protocols have made half-matched transplants as safe as traditional full-match procedures.

A heart transplant is a major life-saving procedure in which a failing or diseased heart is replaced with a healthy donor heart. It restores normal heart function, improves quality of life, and is recommended when other treatments no longer work.

When You Should Consider a Heart Transplant

• Severe heart failure not improving with medicines or procedures

• Frequent hospital admissions due to worsening heart condition

• Extreme fatigue, weakness, or breathlessness during simple tasks

• Swelling in legs, ankles, or abdomen because of fluid buildup

• Life-threatening arrhythmias that cannot be controlled

• Poor heart pumping capacity despite advanced treatment

Conditions That May Require a Heart Transplant

• Dilated or restrictive cardiomyopathy

• Severe coronary artery disease with repeated heart attacks

• Congenital heart defects not treatable with surgery

• End-stage valvular heart disease

• Severe myocarditis causing permanent heart damage

• Heart failure after previous surgeries or device implants

How Heart Transplant Surgery Is Performed

• General anesthesia is given for complete comfort

• The weakened or failing heart is surgically removed

• A healthy donor heart is connected to major blood vessels

• The new heart is started carefully to ensure proper function

• Monitoring lines and drains are placed for recovery

• You are shifted to the ICU for close observation

Pre-Surgery Preparation

• Heart function tests and blood/tissue matching

• Follow all fasting and medication-related instructions

• Maintain controlled blood pressure, blood sugar, and healthy weight

• Avoid alcohol and stop smoking at least 3–4 weeks before surgery

• Attend counseling to prepare mentally and physically

Pre-Surgery Tests

• ECG to check heart rhythm

• Echocardiography to assess pumping capacity

• CT or MRI scans for detailed imaging

• Pulmonary function tests for lung strength

• Blood typing and tissue matching

• Coronary angiography, if required

Life After a Heart Transplant

• ICU stay: usually 3–5 days

• Hospital recovery: around 2–3 weeks

• Regular follow-ups to monitor organ acceptance

• Anti-rejection medicines taken lifelong

• Gradual return to daily activities in 8–12 weeks

• Healthy diet, low-salt meals, and light exercise

• Cardiac rehabilitation for long-term recovery

Benefits of a Heart Transplant

• Better heart function and improved blood flow

• Relief from breathlessness, fatigue, and swelling

• Fewer hospital visits and emergency episodes

• Better stamina and improved quality of life

• Long-term survival with the right care and medicines

Kidney transplant surgery is a life-saving procedure where a healthy kidney from a donor (living or deceased) is placed into a patient with end-stage renal disease (ESRD). It is generally the preferred treatment over lifelong dialysis, offering a significantly better quality of life and higher long-term survival rates. This procedure restores the body's ability to filter waste and maintain fluid balance naturally.

When You Should Consider a Kidney Transplant

• End-Stage Renal Disease (ESRD): When your kidneys have lost approximately 90% of their function due to chronic conditions.

• Diabetes Mellitus: One of the leading causes of kidney failure that can be effectively managed through transplantation.

• Chronic High Blood Pressure: Persistent hypertension that has caused irreversible damage to the kidney's filtering units (nephrons).

• Polycystic Kidney Disease (PKD): A genetic disorder causing numerous cysts to grow in the kidneys, eventually leading to failure.

• Preemptive Transplant: For patients whose kidney function is declining but who have not yet started dialysis, as this often leads to the best long-term outcomes.

How Is Performed

• Anesthesia: The operation is performed under general anesthesia and typically takes between 3 to 4 hours.

• Placement: The donor kidney is placed in the lower abdomen (usually the right or left groin area).

• Native Kidneys: Your original kidneys are generally left in place unless they are causing specific complications like chronic infection or severe high blood pressure.

• Vascular Connections: The donor kidney's artery and vein are surgically attached to your existing iliac blood vessels in the lower abdomen to establish blood flow.

• Ureteral Connection: The donor's ureter (the tube that carries urine) is connected directly to your bladder to allow for natural voiding.

• Monitoring: Once blood starts flowing, the new kidney often begins producing urine immediately, though it can sometimes take several days to fully "wake up."

Pre-Procedure Preparation

• Transplant Evaluation: A comprehensive series of medical, surgical, and psychological tests to ensure you are a suitable candidate for the procedure.

• Compatibility Testing: Blood typing (A, B, AB, or O) and tissue typing (HLA matching) to find the best possible donor match.

• Crossmatch Test: A final blood test mixed with the donor's cells to ensure your immune system will not immediately attack the new organ.

• Dental and Cancer Screenings: Ensuring there are no active infections or undiagnosed malignancies that could be exacerbated by anti-rejection medication.

• Fasting: Following strict "nothing by mouth" instructions for 8 hours prior to your scheduled surgery.

Tests Before Kidney Transplant

• Echocardiogram: A detailed heart ultrasound to ensure your cardiovascular system can handle the surgery.

• Chest X-ray: To rule out any active lung infections or fluid buildup prior to anesthesia.

• Panel Reactive Antibody (PRA) Test: Measures the level of antibodies in your blood to determine how difficult it will be to find a compatible match.

• CT Scan of the Pelvis: To evaluate the blood vessels in the lower abdomen where the new kidney will be attached.

• ECG: A routine heart check to confirm cardiac stability for the duration of the procedure.

Life After Kidney Transplant

• Hospital Stay: Typically lasts 3 to 7 days for the recipient to monitor organ function and manage post-operative pain.

• Lifelong Medication: You must take immunosuppressant (anti-rejection) drugs daily for the rest of your life to prevent your immune system from attacking the new kidney.

• Physical Restrictions: Avoid lifting objects heavier than 4.5 kg (10 lbs) for at least 6 to 8 weeks to allow the abdominal wall to heal.

• Driving and Work: Driving is usually restricted for 2 to 6 weeks, and most people can return to professional work within 8 to 12 weeks.

• Dietary Adjustments: While restrictions are fewer than on dialysis, you must avoid raw/undercooked foods and grapefruit/grapefruit juice, which can dangerously interfere with anti-rejection medications.

Why Specialized Treatment Is Highly Effective

• Eliminates Dialysis: A successful transplant removes the need for time-consuming dialysis treatments, providing true freedom and independence.

• Higher Energy Levels: Restoring natural kidney function helps correct anemia and remove toxins, leading to significantly increased vitality.

• Fewer Dietary Restrictions: Patients can enjoy a much broader range of foods and fluids compared to the strict limitations of a renal diet.

• Improved Long-term Survival: Statistics consistently show that transplant recipients live longer than patients who remain on long-term dialysis.

• Cost-Effective Care: While the initial surgery is intensive, the long-term cost of maintaining a healthy transplant is much lower than the ongoing cost of dialysis.

A lung transplant is a major surgical procedure to replace one or both diseased lungs with healthy donor lungs. It is typically a treatment of last resort for end-stage lung diseases that no longer respond to other medical therapies. The goal is to improve the patient's quality of life and extend life expectancy when other options have been exhausted.

When You Should Consider a Lung Transplant

• End-Stage COPD (Emphysema): When chronic obstructive pulmonary disease has caused such severe damage that breathing is difficult even with supplemental oxygen.

• Idiopathic Pulmonary Fibrosis: Progressive scarring of the lung tissue that prevents the lungs from transferring oxygen into the bloodstream.

• Cystic Fibrosis: A genetic condition causing thick, sticky mucus to build up in the lungs, leading to repeated, life-threatening infections.

• Pulmonary Hypertension: High blood pressure in the arteries of the lungs that can eventually lead to right-sided heart failure.

• Alpha-1 Antitrypsin Deficiency: A genetic disorder that can cause severe lung and liver disease.

Types of Lung Transplant

• Single Lung Transplant: Replaces one damaged lung. This is often used for certain restrictive diseases like pulmonary fibrosis.

• Double (Bilateral) Lung Transplant: Replaces both lungs simultaneously. This is the primary choice for infectious diseases like cystic fibrosis to ensure no infected tissue remains.

• Heart-Lung Transplant: A rare procedure that replaces the heart and both lungs, usually for patients with severe pulmonary hypertension and concomitant heart failure.

How Is Performed

• Anesthesia: The procedure is highly complex and performed under general anesthesia.

• Duration: A single transplant usually takes 4 to 8 hours, while a double transplant can take 6 to 12 hours.

• Incision: For a single lung, an incision (thoracotomy) is made on the side of the chest. For a double lung, a horizontal "clamshell" incision is often made across the chest.

• Support: During the surgery, you may be connected to a heart-lung bypass machine or ECMO (Extracorporeal Membrane Oxygenation) to circulate blood and oxygen.

• Connection: Surgeons meticulously sew the new lung's main airway (bronchus) and major blood vessels (pulmonary artery and veins) to your own.

Pre-Procedure Preparation

• Transplant Evaluation: An extensive series of tests to ensure you are healthy enough for surgery and committed to a lifelong post-transplant regimen.

• Psychological Assessment: To evaluate your support system and ability to manage complex medication schedules.

• Pulmonary Rehab: Engaging in specialized exercise to keep your body as strong as possible while waiting for a donor match.

• Vaccinations: Ensuring all immunizations are up to date, as your immune system will be suppressed after surgery.

• The Waiting List: Once approved, you are placed on a national registry where donor lungs are matched based on blood type, organ size, and geographic distance.

Tests Before Lung Transplant

• Pulmonary Function Tests (PFTs): To measure exactly how much air your lungs can hold and how well they move gases.

• Cardiac Catheterization: To check the pressure in your lung arteries and the overall strength of your heart.

• Chest CT Scan: Providing high-resolution 3D images of your lung structure and chest cavity.

• Tissue Typing: Matching your tissue markers with potential donors to reduce the risk of immediate organ rejection.

• ECG and Stress Test: Ensuring your heart can withstand the rigors of a multi-hour major surgery.

Life After Lung Transplant

• Hospital Stay: Typically 1 to 3 weeks, with the first several days spent in the Intensive Care Unit (ICU) on a mechanical ventilator.

• Lifelong Medication: You must take immunosuppressant (anti-rejection) drugs for the rest of your life to prevent your body from attacking the new lung.

• Monitoring: Frequent follow-up visits, blood tests, and bronchoscopies (using a camera to look inside the lungs) are required, especially in the first year.

• Physical Rehab: You will start walking within days of surgery and gradually progress to light exercise over 6 to 8 weeks.

• Lifestyle Adjustments: Avoiding crowds during flu season, wearing masks in certain environments, and strict food safety are necessary to prevent infections.

Why Specialized Treatment Is Highly Effective

• Significant Survival Benefit: For many patients with end-stage disease, a transplant can extend life expectancy by many years.

• Restored Breathing: Patients often transition from being housebound on oxygen to walking, traveling, and engaging in physical hobbies.

• Advanced Surgical Support: The use of ECMO technology allows surgeons to perform transplants on the most critically ill patients with greater safety.

• Comprehensive Care Teams: Post-transplant care involves a dedicated team of pulmonologists, surgeons, pharmacists, and coordinators to manage every aspect of recovery.

• Improved Quality of Life: Beyond just survival, a successful transplant provides the "gift of breath," allowing for a return to a much more normal and active lifestyle.